Pharmaceutical kits comprising mesenchymal stem cells
AssigneeQuy Biosciences Limited
InventorsRoger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon William Blunn
Life of this patent
Estimating the term…
Abstract
A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
Claims22
1-20. (canceled)
A composition of mesenchymal stem cells (MSCs) or MSCs and tenocytes derived therefrom in a liquid suspension of bone marrow supernatant wherein the composition of MSCs is enriched compared to a natural source of the MSCs.
Dependencies are inferred from the claim text.